Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of the Efficacy and Safety of Different Duration of Proton Pump Inhibitor for Prevention of Upper Gastrointestinal Mucosal Injury in Patients Taking 12-month Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery

Trial Profile

Evaluation of the Efficacy and Safety of Different Duration of Proton Pump Inhibitor for Prevention of Upper Gastrointestinal Mucosal Injury in Patients Taking 12-month Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Jul 2018

At a glance

  • Drugs Pantoprazole (Primary)
  • Indications Gastric ulcer
  • Focus Adverse reactions
  • Acronyms DACAB-GI-2
  • Most Recent Events

    • 15 Jul 2018 Planned End Date changed from 1 Mar 2020 to 1 Sep 2020.
    • 15 Jul 2018 Planned primary completion date changed from 1 Mar 2019 to 1 Sep 2019.
    • 15 Jul 2018 Planned initiation date changed from 1 Apr 2018 to 1 Oct 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top